Moshe C. Ornstein MD MA, Laura S. Wood RN MSN OCN, Kimberly Allman MSN CNP, Allison Martin PA-C Timothy Gilligan MD, Jorge A. Garcia MD, Brian I. Rini MD Cleveland Clinic Taussig Cancer Institute discusses Phase II trial of intermittent nivolumab From the Seventeenth International Kidney Cancer International Symposium 2018 in Miami FL.
